2022
New Onset Isolated Granulomatous Dacryoadenitis During Etanercept Therapy
Arat Y, Aygün F, Özoğul E, Kalyoncu U. New Onset Isolated Granulomatous Dacryoadenitis During Etanercept Therapy. Ocular Immunology And Inflammation 2022, 31: 1727-1729. PMID: 35797360, DOI: 10.1080/09273948.2022.2089687.Peer-Reviewed Original ResearchConceptsEtanercept therapyLacrimal glandLeft upper eyelid swellingAnti-tumor necrosis factor alphaUpper eyelid swellingLeft lacrimal glandRight lacrimal glandSarcoid-like granulomatosisNecrosis factor-alphaJuvenile idiopathic arthritisAntagonist therapyEyelid swellingIncisional biopsySubcutaneous etanerceptDiffuse enlargementFactor-alphaTNF-aDacryoadenitisIdiopathic arthritisMinimal enlargementTherapyBiological agentsEtanerceptGlandEnlargement
2011
Orbitofacial neurofibromatosis: clinical characteristics and treatment outcome
Chaudhry I, Morales J, Shamsi F, Al-Rashed W, Elzaridi E, Arat Y, Jacquemin C, Oystreck D, Bosley T. Orbitofacial neurofibromatosis: clinical characteristics and treatment outcome. Eye 2011, 26: 583-592. PMID: 22193879, PMCID: PMC3325560, DOI: 10.1038/eye.2011.336.Peer-Reviewed Original ResearchConceptsSurgical interventionNon-comparative case seriesDecreased visual acuityNeurofibromatosis type 1Ophthalmologic examinationOphthalmological monitoringPtosis repairTumor debulkingEyelid swellingVisual acuityResultsSixty patientsSurgical managementCase seriesPresenting signCosmetic consequencesCosmetic rehabilitationProcedural outcomesPatientsMedical recordsType 1Medical CentreMultiple proceduresClinical observationsDemographic dataPtosis